JamileShammoMD, FASCP, FACP
Hematology • Chicago, ILHematologic Oncology, Myeloproliferative Disorder Hematology-Oncology
Professor of Medicine Division of Hematology Oncology Northwestern University
Dr. Shammo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
645 N. Michigan Avenue
Suite 1020
Chicago, IL 60611
Education & Training
University of ChicagoFellowship, Hematology and Medical Oncology, 1996 - 1999
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1991 - 1995- University of Chicago (NorthShore)Residency, Pathology-Anatomic and Clinical, 1988 - 1991
University of Aleppo Faculty of MedicineClass of 1985
Certifications & Licensure
IL State Medical License 1991 - 2026- American Board of Internal Medicine Hematology
- American Board of Pathology Anatomic Pathology & Clinical Pathology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Phase 2, Open-Label, Multi-Dose Study of Panhematin in Patients With MDS Start of enrollment: 2007 May 01
- CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib Start of enrollment: 2010 Nov 01
- A Trial of Lenalidomide & Azacitidine in Low Risk Myelodysplastic Syndromes Start of enrollment: 2011 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsExpert consensus on the management of pharmacodynamic breakthrough-hemolysis in treated paroxysmal nocturnal hemoglobinuria.David Dingli, Carlos De Castro Iii, Jamie Koprivnikar, Austin Kulasekararaj, Jaroslaw Maciejewski
Hematology. 2024-12-01 - 1 citationsParoxysmal nocturnal hemoglobinuria: Review of the patient experience and treatment landscape.Anem Waheed, Jamile Shammo, David Dingli
Blood Reviews. 2024-03-01 - 2 citationsLiver fibrosis and its response to avapritinib in 2 patients with systemic mastocytosis.Karla Cavazos, Sheila Eswaran, Cathleen Maidlow, Fatma Keklik Karadag, Ramazan Idilman
Blood Advances. 2022-10-25
Abstracts/Posters
- Epidemiology of PNH and Real-World Treatment Patterns Following an Incident PNH Diagnosis in the USJamile M. Shammo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- A Novel Patient Reported Outcome Instrument Assessing the Symptoms of Paroxysmal Nocturnal HemoglobinuriaJamile M. Shammo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Persistent Leukocytosis in Polycythemia Vera Is Associated with Disease Evolution but Not Thrombosis: An Analysis from a 520-Patient Retrospective Multi-Center DatabaseJamile M. Shammo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Lectures
- Phase 2 Expansion Study of Oral Rigosertib Combined with Azacitidine (AZA) in Patients (Pts) with Higher-Risk (HR) Myelodysplastic Syndromes (MDS): Efficacy and Safety...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Riding the Wave: Clinical Management of Myeloid Malignancies in an Era of Novel Therapies60th American Society of Hematology Annual Meeting - 11/30/2018
Authored Content
- Hereditary Hemochromatosis Manifesting After Treatment of Paroxysmal Nocturnal Hemoglobinuria with EculizumabOctober 2017
Press Mentions
- ASH Announces Executive Committee Election Results, New Clinical Practice Guidelines, and MoreNovember 5th, 2020
Diagnosis of Myelodysplastic SyndromeJanuary 29th, 2020
Repurposed Drug Gives Woman with Cancer the Gift of LifeJuly 1st, 2018- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
